InvestorsHub Logo
Followers 46
Posts 6281
Boards Moderated 0
Alias Born 06/17/2009

Re: None

Friday, 02/07/2020 10:16:59 AM

Friday, February 07, 2020 10:16:59 AM

Post# of 463347

While our enrollment and early data have been exciting, we are humbled by the needs of the rare disease and Alzheimer’s and Parkinson’s disease communities with whom we engage. They impress a sense of urgency on our work to deliver a new paradigm that underscores the need for new treatment options for patients and their families.



To me, this is the most meaningful statement from the PR and CC. I believe this is the first time he has mentioned the interaction with patients.

TGD and everyone at Anavex, as do we shareholders, now know that the patient population with families & friends are desperate to find cures and/or remedies and that those folks are seeing such in the 2-73 trials that are ongoing. Anavex 2-73 is not failing the patients but is providing hope for a better life for all impacted by these dread diseases. I'm sure many a tear or 100's were shed during these talks as my eyes get moist even thinking about the happiness 2-73 is bringing to them.

May God bless the Anavex family.


ANAVEX NOW ... MONO-STYLE ... RWEm for Life ... and for ALL AGES!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News